If you've been managing a diagnosis of polycystic ovary syndrome, or if you've spent years chasing answers that never quite added up, there's something you should know. On May 12, 2026, a global consensus published in The Lancet officially renamed PCOS to PMOS: polyendocrine metabolic ovarian syndrome.

This is not a rebrand. For the millions of women living with this condition, including many here in Las Vegas, it reflects a hard-won correction in how medicine has understood and communicated what PMOS actually is.

At Evolve Gynecology, we've long approached this condition as the complex, whole-body hormonal disorder it is. The name finally caught up.

Why the Old Name Was a Problem

"Polycystic ovary syndrome" implied that cysts on the ovaries were the defining feature of the condition. They aren't. What shows up on ultrasound are arrested follicles, not pathological cysts. This distinction is not semantic; it shaped how the condition was diagnosed, treated, and understood by patients for decades.

The consequences were real. Research documented diagnostic delays in up to 70% of people with the condition. Many women were told they had PCOS only after fertility became the pressing issue, despite years of earlier symptoms that were overlooked or attributed to something else.

The process to fix this took more than a decade. Over 22,000 clinicians, researchers, and patients participated. The new name was chosen by a nearly unanimous vote across more than 56 clinical and patient organizations worldwide, including the Endocrine Society, the Androgen Excess and PCOS Society, and Verity.

What Each Word in PMOS Actually Means

The name was not chosen to sound sophisticated. Each word addresses a specific gap in the old terminology.

Polyendocrine acknowledges that PMOS involves multiple interacting hormonal systems: insulin, androgens, and neuroendocrine signaling. It is not an ovarian disorder with hormonal side effects. The hormonal disruption is the disorder.

Metabolic reflects what this condition does in the body over time. Insulin resistance, elevated cardiovascular risk, type 2 diabetes, weight dysregulation, and pregnancy complications are not peripheral concerns. They are core features of PMOS that deserve clinical attention from the outset.

Ovarian remains in the name because ovarian function is genuinely affected: menstrual irregularity, altered ovulation, and fertility challenges are real. But they sit within a larger picture, not at the center of it.

What This Means Practically

If you already carry a PCOS diagnosis, nothing about your condition has changed. The biology is the same. What changes is how it gets framed: away from "ovarian problem that also affects hormones" and toward "endocrine-metabolic condition that affects the ovaries, among other systems."

That reframing has clinical weight. The consensus explicitly calls for treatment to target upstream drivers, particularly insulin resistance, rather than managing reproductive symptoms in isolation. Clinical guidelines in 195 countries are being updated to reflect this over the next three years.

For women who have felt that their care addressed only one corner of what they were experiencing, this shift matters.

How We Approach PMOS at Evolve GYN

Dr. Toni Hodges-Wills has always evaluated the full hormonal picture: insulin and metabolic markers, androgen levels, menstrual patterns, cardiovascular risk, mental health, and skin. That is the clinical standard the new name calls for, and it has been our standard from the beginning.

Our concierge gynecology model gives patients time. Not a rushed appointment where one symptom gets addressed and the rest are deferred, but an actual conversation about what you're experiencing and what it connects to. For a condition like PMOS, that matters more than it might for a simpler diagnosis.

Whether you're newly concerned, have had a PCOS diagnosis for years, or have never quite felt that the label fit what you were living with, we can help you work through it.

Schedule a Consultation

Evolve Gynecology serves women across the Las Vegas area, including Summerlin and Spring Valley, through our concierge care model and direct-access appointments. If PMOS, hormonal health, or metabolic wellness has been on your mind, this is a good time to get clear.



Contact us to schedule a consultation with Dr. Hodges, or book an appointment online.

This post reflects the global consensus published in The Lancet on May 12, 2026. As guidelines are updated over the coming three years, Evolve Gynecology will continue to apply the most current clinical standards to your care.